(Q37717051)

22 August 2017

1 reference

title

Converting enzyme, angiotensin II and hypertensive disease (English)

2 references

22 August 2017

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

30 May 2022

author name string

R. L. Soffer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A203191

30 May 2022

D. B. Case

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A203191

30 May 2022

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

22 August 2017

https://api.elsevier.com/content/article/PII:0002934378901912?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

https://api.elsevier.com/content/article/PII:0002934378901912?httpAccept=text/plain

30 May 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

American Journal of Medicine

30 May 2022

published in

1 reference

22 August 2017

volume

64

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

147-160

1 reference

The biochemistry of the renin-angiotensin system and its role in hypertension

22 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

30 May 2022

Niere und Kreislauf1

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

30 May 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR

30 May 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

The substance causing renal hypertension

30 May 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

The existence of two forms of hypertensin

30 May 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

The amino acid composition of hypertensin II and its biochemical relationship to hypertensin I.

30 May 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

The preparation and function of the hypertensin-converting enzyme

30 May 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Differentiation between two forms of angiotonin by means of spirally cut strips of rabbit aorta

30 May 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Conversion of angiotensin I to angiotensin II.

30 May 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Fate of angiotensin I in the circulation

30 May 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog Lung

30 May 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA

30 May 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Hydrolysis of bradykinin by angiotensin-converting enzyme

30 May 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom

30 May 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

30 May 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II

30 May 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme

30 May 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Greene LL, Ferreira SH: Potential screening test for detection of overactivity of renin-angiotensin system

30 May 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Angiotensin-converting enzyme from rabbit pulmonary particles

30 May 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Inhibition of angiotensin conversion in experimental renovascular hypertension.

3 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

3 January 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Formation of angiotensin III by angiotensin-converting enzyme

3 January 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Role of the pressor action of angiotensin II in experimental hypertension.

3 January 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

3 January 2023

Angiotensin receptors

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

3 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion.

3 January 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides

3 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Pulmonary angiotensin-converting enzyme antienzyme antibody

3 January 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II)

3 January 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Angiotensin-Converting Enzyme: Vascular Endothelial Localization

3 January 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Angiotensin-converting enzyme: Effect of antienzyme antibody in vivo

3 January 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism

3 January 2023

40

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man

3 January 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Aldosterone secretion and primary and malignant hypertension

3 January 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

3 January 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension

3 January 2023

44

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE.

3 January 2023

45

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

3 January 2023

47

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

3 January 2023

48

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Renovascular hypertension. Mechanisms, natural history and treatment

3 January 2023

49

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Ten years experience with the surgical management of renovascular hypertension

3 January 2023

50

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals

3 January 2023

52

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Inhibition of angiotensin I converting enzyme by venom peptides

3 January 2023

54

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients

3 January 2023

55

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin

3 January 2023

56

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture

3 January 2023

57

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

3 January 2023

58

1 reference

https://api.crossref.org/works/10.1016/0002-9343(78)90191-2

3 January 2023

Identifiers

1 reference

22 August 2017

1 reference